Kerala Ayurveda Share Price Today | Stock Price & Kerala Ayurveda Share Screener
As of October 5, 2026, the live Kerala Ayurveda share price (BSE: KERALAYUR) is ₹146.65, down 0.20% from the previous close, with shares trading between ₹145.25 and ₹154.25 in today's trading session, and a 52-week range of ₹146.30–₹436.55. Check KERALAYUR 52-week chart for the annual price range and momentum. Use the Kerala Ayurveda stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Kerala Ayurveda opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹37 and net income of ₹-7, with EBITDA of ₹-5, an operating margin of -20.0% and a profit margin of -18.9%.
Kerala Ayurveda Share Price Chart
Track the current stock price of Kerala Ayurveda with an interactive chart. Analyse KERALAYUR share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Kerala Ayurveda stock quote in one place.
The quote of ₹146.65 sits between the 52-week low of ₹146.30 and the 52-week high of ₹436.55, and the latest session moved -0.20% from the previous close.
Kerala Ayurveda Company Profile - Fundamental Screener
Screen Kerala Ayurveda company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KERALAYUR shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE817B01025.
Company Details
Classification
Identifiers and Leadership
Kerala Ayurveda Balance Sheet Screener
Screen KERALAYUR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹138, up from ₹129 in 2025.
Latest statistics put total assets at ₹138 and shareholder funds at ₹11, with a leverage ratio of 5.21.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 138 | 129 | 133 | 115 | 110 | 115 | 103 | 92 | 103 | 81 |
| Current Assets | 47 | 41 | 56 | 34 | 37 | 44 | 33 | 28 | 42 | 22 |
| Fixed Assets | 49 | 47 | 41 | 46 | 44 | 33 | 33 | 33 | 33 | 34 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 24 | 28 | 28 | 55 | 42 | 67 | 63 | 59 | 48 | 24 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 11 | 13 | 21 | 8 | 8 | 5 | 10 | 5 | 10 | 9 |
| Share Capital | 13 | 12 | 12 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves & Surplus | -2 | -3 | 7 | -5 | -4 | -7 | -3 | -7 | -3 | -4 |
Kerala Ayurveda Income Statement Screener - Profit & Revenue Analysis
Screen Kerala Ayurveda income statement and profit fundamentals. Analyze KERALAYUR quarterly results. Kerala Ayurveda reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹37 and net profit was ₹-7, equal to earnings per unit of ₹-5.83, at an operating margin of -20%.
In that period expenses were ₹42, interest cost ₹1 and tax ₹-1. The next period listed, 2026-Jun, shows revenue of ₹33 and net profit of ₹-8.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 37 | 33 | 32 | 38 | 37 | 34 | 32 | 28 | 31 | 31 | 24 | 24 | 26 | 27 | 21 |
| Expenses | 42 | 37 | 42 | 33 | 40 | 35 | 27 | 27 | 25 | 32 | 23 | 22 | 25 | 25 | 19 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | -5 | -4 | -9 | 5 | -3 | 0 | 5 | 1 | 6 | -1 | 1 | 2 | 1 | 1 | 2 |
| Operating Profit % | -20.00% | -12.00% | -32.00% | -15.00% | -14.00% | -5.00% | 15.00% | 3.00% | 18.00% | -4.00% | 3.00% | 6.00% | 2.00% | 4.00% | 10.00% |
| Depreciation | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 3 | 3 | 1 | 3 | 3 | 3 | 1 | 1 | 0 | 1 | 2 | 1 | 1 | 2 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | -8 | -8 | -14 | 3 | -7 | -4 | 0 | 0 | 4 | -2 | -1 | 0 | 0 | 0 | 0 |
| Tax | -1 | 0 | 2 | 1 | -1 | 0 | 0 | 0 | 0 | 1 | -1 | 0 | 0 | 1 | 0 |
| Net Profit | -7 | -8 | -15 | 2 | -6 | -5 | 1 | 1 | 4 | -3 | 1 | 0 | 0 | -1 | 0 |
| EPS | -5.83 | -6.24 | -12.78 | 1.92 | -7.23 | -3.81 | 0.50 | 0.33 | 3.10 | -2.40 | 0.24 | -3.24 | 0.07 | -0.84 | 0.06 |
Kerala Ayurveda Cash Flow Screener - Liquidity Fundamentals
Screen KERALAYUR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹5, and net cash flow was an outflow of ₹19.
Over the same period, investing activities used ₹15 and financing activities used ₹10.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 5 | -1 | 10 | -1 | 7 | 5 | 12 | -10 | 4 | 6 |
| Investing Activities | -15 | 0 | -7 | -2 | -1 | -4 | -3 | -3 | -3 | -3 |
Financing and Net Cash | ||||||||||
| Financing Activities | -10 | 20 | -2 | -13 | 6 | 1 | -12 | 17 | 0 | -2 |
| Net Cash Flow | -19 | 18 | 0 | -16 | 12 | 2 | -2 | 4 | 1 | 0 |
Kerala Ayurveda Shareholding Pattern Screener
See Kerala Ayurveda shareholding pattern with promoter, FII, and DII holdings. Check Kerala Ayurveda promoter holding and ownership changes for KERALAYUR on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jun, promoters held 35.61%, foreign institutions 0.17%, domestic institutions 0.04% and the public 42.02%, spread across 10,372 shareholders.
The shareholder count was 10,372 in 2026-Jun, compared with 10,184 in 2026-Mar.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 35.61% | 35.61% | 33.14% | 33.14% | 37.83% | 58.58% | 58.58% | 58.58% |
Institutional Investors | ||||||||
| FII Holding | 0.17% | 0.17% | 0.22% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 42.02% | 42.16% | 44.42% | 44.36% | 41.26% | 32.23% | 32.19% | 32.24% |
| Other Holding | 22.17% | 22.03% | 22.18% | 22.46% | 20.87% | 9.15% | 9.20% | 9.14% |
| Shareholder Count | 10,372 | 10,184 | 9,952 | 9,938 | 9,401 | 9,074 | 9,009 | 9,052 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Kerala Ayurveda. Kerala Ayurveda dividend yield can be compared with peers and other stocks in the market.
Kerala Ayurveda Stock Index Membership - Nifty & Sensex
See which indices include Kerala Ayurveda stock. Check KERALAYUR index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Kerala Ayurveda Market Events Screener - Corporate Actions
Get Kerala Ayurveda corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Kerala Ayurveda stock events that may affect KERALAYUR share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 28, 2026, with a record date of September 28, 2026.
It is followed by Quarterly Result Announcement dated August 12, 2026 and Quarterly Result Announcement dated May 25, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-28 | 2026-09-28 | Annual General Meeting | NA | -8.59% |
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | -0.61% |
| 2026-05-25 | 2026-05-25 | Quarterly Result Announcement | NA | 3.07% |
| 2026-03-14 | 2026-03-14 | Extraordinary General Meeting | NA | -30.44% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | -1.04% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -2.13% |
| 2025-09-26 | 2025-09-26 | Annual General Meeting | NA | -6.82% |
| 2025-07-18 | 2025-07-18 | Quarterly Result Announcement | NA | -0.01% |
| 2025-06-18 | 2025-06-18 | Extraordinary General Meeting | NA | 16.59% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | -7.92% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -4.92% |
| 2025-01-03 | 2025-01-03 | Extraordinary General Meeting | NA | 19.17% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -4.46% |
| 2024-09-20 | 2024-09-20 | Annual General Meeting | NA | -4.67% |
| 2023-12-20 | 2023-12-20 | Extraordinary General Meeting | NA | 6.04% |
Kerala Ayurveda Competitors Screener - Peer Stocks Comparison
Screen KERALAYUR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 430,465 | 35.84 | 61,674 | 12.69% | 11,565 | 36.68 |
| Divis Laboratories | 242,373 | 84.36 | 11,067 | 13.95% | 2,568 | 51.70 |
| Torrent Pharmaceuticals | 179,381 | 84.01 | 13,886 | 20.34% | 2,138 | 41.12 |
| Zydus Life Science | 112,728 | 24.88 | 27,658 | 17.64% | 5,026 | 47.64 |
| Cipla | 107,736 | 32.42 | 29,045 | 2.24% | 3,870 | 34.78 |
| Laurus Labs | 106,528 | 98.56 | 6,868 | 22.01% | 890 | 58.70 |
| Mankind Pharma | 104,178 | 50.48 | 14,636 | 14.85% | 1,938 | 61.75 |
| Dr Reddys Laboratories | 100,312 | 31.47 | 35,059 | 3.90% | 4,158 | 53.84 |
| Aurobindo Pharma | 96,157 | 25.97 | 34,145 | 5.56% | 3,503 | 50.30 |
| Lupin | 91,865 | 16.71 | 29,039 | 26.75% | 5,356 | 31.59 |
Kerala Ayurveda Company Announcements - News & Reports Screener
Screen KERALAYUR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 1, 2026.
The next most recent announcements are dated September 30, 2026 and September 30, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-30 | Summary Of Proceedings Of AGM. | - |
| 2026-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-30 | Closure of Trading Window | - |
| 2026-09-23 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-22 | Corrigendum To The Notice Of The 34Th Annual General Meeting Of Kerala Ayurveda Limited To Be Held On September 28 2026. | - |
| 2026-09-22 | Announcement under Regulation 30 (LODR)-Preferential Issue | - |
| 2026-09-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-05 | Notice Of 34Th Annual General Meeting Of Kerala Ayurveda Limited | - |
| 2026-09-05 | Reg. 34 (1) Annual Report. | - |
| 2026-09-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-04 | Announcement under Regulation 30 (LODR)-Preferential Issue | - |
| 2026-09-01 | Board Meeting Intimation for Preferential Issue Of Shares And Intimation About AGM | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-08-12 | Results-Financial Results For The Quarter Ended 30Th June 2026 | - |
| 2026-08-12 | Board Meeting Outcome for Outcome Of Board Meeting 12Th August 2026 | - |
| 2026-08-06 | Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2026. | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹146.65, within a 52-week range of ₹146.30 to ₹436.55. The P/E ratio is -7.22 and the P/B ratio is 16.71, with earnings per unit of ₹-13.53. Market capitalisation stands at ₹192.49 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.